Enanta Pharmaceuticals Inc (NASDAQ:ENTA) shares, rose in value on Thursday, April 16, with the stock price up by 3.45% to the previous day’s close as strong demand from buyers drove the stock to $5.10.
Actively observing the price movement in the last trading, the stock closed the session at $4.93, falling within a range of $4.83 and $5.225. The value of beta (5-year monthly) was 0.696. Referring to stock’s 52-week performance, its high was $17.24, and the low was $4.09. On the whole, ENTA has fluctuated by -20.81% over the past month.
With the market capitalization of Enanta Pharmaceuticals Inc currently standing at about $108.80 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-09.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 63.36M, with a low estimate of 14.5M and a high estimate of 17M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 15.96M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ENTA’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of ENTA currently trading nearly -2.30% and -18.82% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 43.45, while the 7-day volatility ratio is showing 10.28% which for the 30-day chart, stands at 8.47%. Furthermore, Enanta Pharmaceuticals Inc (ENTA)’s beta value is 0.85, and its average true range (ATR) is 0.47.
A comparison of Enanta Pharmaceuticals Inc (ENTA) with its peers suggests the former has fared considerably weaker in the market. ENTA showed an intraday change of 3.45% in last session, and over the past year, it shrunk by -66.80%%.
Data on historical trading for Enanta Pharmaceuticals Inc (NASDAQ:ENTA) indicates that the trading volumes over the past 10 days have averaged 0.35 and over the past 3 months, they’ve averaged 370.53K. According to company’s latest data on outstanding shares, there are 21.33 million shares outstanding.
Nearly 7.09% of Enanta Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 95.44% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 2.67 million shares as on 2025-03-31, resulting in a short ratio of 11.56. According to the data, the short interest in Enanta Pharmaceuticals Inc (ENTA) stood at 1328.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 2.6 million. The stock has fallen by -11.30% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ENTA stock heading into the next quarter.
